RealClear Health

RealClearHealth (RCH) gathers the most important news and viewpoints related to the health care discussion. RCH not only helps readers stay informed by curating relevant content but also creates original articles that delve into crucial health policy topics. As part of RealClear Media Group (RCMG), which includes 15 different brands covering a wide range of interests, RealClearHealth is dedicated to providing valuable insights. Explore more at realclearmediagroup.com today.

National

English

Press release/News aggregator

Outlet metrics

Domain Authority

Ranking

Global

#657632

United States

#148582

News and Media

#5160

Traffic sources

Monthly visitors

Articles

Stop Overprotecting the Children

Jan 7, 2025 | realclearhealth.com | Elizabeth Nolan Brown
Healthcare Trends Shaping 2025 | RealClearHealth

Dec 31, 2024 | realclearhealth.com | David Carmouche

As 2025 begins, the healthcare industry stands at a pivotal juncture. Escalating costs, evolving political priorities, an alarming frustration with claims denials, and rapid technological advancements
Harvard's New Study on Healthy Aging

Aug 5, 2024 | realclearhealth.com | Matt Fuchs

Seven lessons for those looking to eat better and live longer.
Wuhan's Unsolved Question

May 2, 2024 | realclearhealth.com | Will Jones

Will Jones Brownstone Institute May 2, 2024 The apparent cluelessness of the Chinese Government until the sequence was published, and the abrupt switch afterwards to something that looks a lot like a biosecurity response, indicates the Chinese Government may have been alerted to the leak only after the sequence was published. Show comments Hide Comments Related Articles
A Lack of Transparency Drives PBM Fees and Restrictions, Reducing Competition

Feb 28, 2024 | realclearhealth.com | Justin Leventhal

Recently pharmacy benefit managers (PBMs) have been at the center of criticism regarding high pharmaceutical prices, and with good reason. Among the top accusations are siphoning savings intended for safety net hospitals in the 340B drug safety net program, restricting access to more than 1,150 medicines, and concerns that the three largest PBMs now account for 80 percent of the market.
Biden’s Price Control Scheme Harms Patients

Sep 7, 2023 | realclearhealth.com | Tom Price

On Tuesday, the Biden administration named the first 10 prescription drugs that will be subject to new government price controls. The novel power is derived from the Inflation Reduction Act (IRA), which permits the federal government to price-fix certain medications that are accessed through Medicare. Democrats will cheerlead the heavy-handed move as a win while ignoring the unintended consequences.